Might psoriasis be a risk factor for obstructive sleep apnea syndrome?

Sleep and Breathing

Volumn 17, Issue 1, 2013, Pages 275-280

  Karaca, Semsettin ^a   Fidan, Fatma ^b   Erkan, Faruk ^a   Nural, Serkan ^a   Pinarcı, Tulay ^a   Gunay, Ersin ^a   Unlu, Mehmet ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b Sema Hastanesi Istanbul   (Turkey)

Author keywords

Comorbidities; Obstructive sleep apnea; Polysomnography; Psoriasis

Indexed keywords

CYCLOSPORIN; ETRETIN; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; COMPARATIVE STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MALE; PHOTOTHERAPY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RISK FACTOR; SLEEP DISORDERED BREATHING; SYSTEMIC THERAPY;

EID: 84874190006     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-012-0686-2     Document Type: Article

References (38)

1. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982-986
2. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 58:826-850
3. West SD, McBeath HA, Stradling JR (2009) Obstructive sleep apnoea in adults. BMJ 338:b1165
4. Tishler PV, Larkin EK, Schluchter MD, Redline S (2003) Incidence of sleep disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 289:2230-2237
5. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217-1239
6. Partinen M (1995) Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med 1:482-487
7. Fidan H, Fidan F, Unlu M, Ela Y, Ibis A, Tetik L (2006) Prevalence of sleep apnoea in patients undergoing operation. Sleep Breath 10:161-165
8. Shepard JW (1992) Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 13:437-458
9. Buslau M, Benotmane K (1998) Cardiovascular complications of psoriasis: does obstructive sleep apnoea play a role? Acta Dermatol Venerol 79:234
10. Patel RV, Shelling ML, Prodanovich S, Federman DG, Kirsner RS (2011) Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med 26(9):1036-1049
11. Ghazizadeh R, Shimizu H, Tosa M, Ghazizadeh M (2010) Pathogenic mechanisms shared between psoriasis and cardiovascular disease. Int J Med Sci 7(5):284-289
12. Ozturkcan S, Ermertcan AT, Eser E, Sahin MT (2006) Cross validation of the Turkish version of ermatology life quality index. Int J Dermatol 45(11):1300-1307
13. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540-545
14. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques, and scoring system for sleep stages in human subjects. Brain Information Service, UCLA, Los Angeles
15. Iber C, Ancoli-Israel S, Chesson A, Quan S, For the American Academy of Sleep Medicine (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, Westchester
16. Lavie P, Herer P, Hoffstein V (2000) Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br Med J 320:479-482
17. Guasti L, Marino F, Cosentino M, Maroni L, Maresca AM, Colombo F, Maio RC, Castiglioni L, Saporiti F, Loraschi A, Gaudio G, Bernasconi A, Laurita E, Grandi AM, Venco A (2011) Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea. Sleep Breath 15:3-11
18. Wu Y, Mills D, Bala M (2008) Psoriasis: cardiovascular risk factors and other disease comorbidities. J Drugs Dermatol 7:373-377
19. Azfar RS, Gelfand JM (2008) Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 20:416-422
20. Christophers E (2007) Comorbidities in psoriasis. Clin Dermatol 25:529-534
21. Gowda S, Goldblum OM, McCall WV, Feldman SR (2010) Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 63(1):114-123
22. Rhew EY, Ramsey-Goldman R (2006) Premature atherosclerotic disease in systemic lupus erythematosus, role of inflammatory mechanisms. Autoimmun Rev 5:101-105
23. Dessein PH, Stanwix AE, Joffe BI (2002) Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 4:R5
24. Asanuma Y, Chung CP, Oeser A, Shintani A, Stanley E, Raggi P, Stein CM (2006) Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol 33:539-545
25. Callis Duffin K, Wong B, Horn EJ, Krueger GG (2009) Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol 60(4):604-879
26. Choi JK, Kim MY, Kim JK, Park JK, Oh SS, Koh SB, Eom A (2011) Association between short sleep duration and high Incidence of metabolic syndrome in midlife women. Tohoku J Exp Med 225(3):187-193
27. Gupta AK, Goldfarb MT, Ellis CN, Voorhees JJ (1989) Side-effect profile of acitretin therapy in psoriasis. J Am Acad Dermatol 20:1088-1093
28. Berth-Jones J (2005) The use of ciclosporin in psoriasis. J Dermatolog Treat 16:258-277
29. Van den Borne BE, Landewé RB, Houkes I, Schild F, van der Heyden PC, Hazes JM, Vandenbroucke JP, Zwinderman AH, Goei The HS, Breedveld FC, Bernelot Moens HJ, Kluin PM, Dijkmans BA (1998) No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis Rheum 41:1930-1937
30. Stern RS, Fitzgerald E, Ellis CN, Lowe N, Goldfarb MT, Baughman RD (1995) The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study. J Am Acad Dermatol 33:44-52
31. Dixon WG, Watson KD, Lunt M, Hyrich KL (2007) Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 56:2905-2912
32. Nishida K, Okada Y, Nawata M, Saito K, Tanaka Y (2008) Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. Endocr J 55:213-216
33. Komai N, Morita Y, Sakuta T, Kuwabara A, Kashihara N (2007) Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 17:385-390
34. Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173-1177
35. Van Halm VP, Nurmohamed MT, Twisk JW, Dijkmans BA, Voskuyl AE (2006) Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 8:R151
36. Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS (2005) Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 52:262-267
37. Alexandroff AB, Pauriah M, Camp RD, Lang CC, Struthers AD, Armstrong DJ (2009) More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. Br J Dermatol 161(1):1-7
38. Davies RJO, Stradling JR (1996) The epidemiology of sleep apnoea. Thorax 51:S65-S70